Mark A. Goldsmith - 24 Oct 2023 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Issuer symbol
RVMD
Transactions as of
24 Oct 2023
Net transactions value
+$17,150
Form type
4
Filing time
24 Oct 2023, 19:21:13 UTC
Previous filing
20 Sep 2023
Next filing
20 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $17,150 +35,000 +10% $0.4900* 384,332 24 Oct 2023 Direct F1
holding RVMD Common Stock 35,424 24 Oct 2023 Trust F2
holding RVMD Common Stock 35,424 24 Oct 2023 Trust F3
holding RVMD Common Stock 327,547 24 Oct 2023 Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -35,000 -34% $0.000000 67,446 24 Oct 2023 Common Stock 35,000 $0.4900 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 174,000 restricted stock units.
F2 Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F3 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F4 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Remarks:

President and Chief Executive Officer